Cargando…
Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier GmbH
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696019/ http://dx.doi.org/10.1016/j.eujim.2021.101979 |
_version_ | 1784619712039092224 |
---|---|
author | Liang, Shi-Bing Zhang, Ying-Ying Fang, Min Liang, Chang-Hao Lan, Hui-Di Shen, Chen Yan, Li-Jiao Hu, Xiao-Yang Han, Mei Robinson, Nicola Liu, Jian-Ping |
author_facet | Liang, Shi-Bing Zhang, Ying-Ying Fang, Min Liang, Chang-Hao Lan, Hui-Di Shen, Chen Yan, Li-Jiao Hu, Xiao-Yang Han, Mei Robinson, Nicola Liu, Jian-Ping |
author_sort | Liang, Shi-Bing |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8696019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier GmbH |
record_format | MEDLINE/PubMed |
spelling | pubmed-86960192021-12-23 Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials Liang, Shi-Bing Zhang, Ying-Ying Fang, Min Liang, Chang-Hao Lan, Hui-Di Shen, Chen Yan, Li-Jiao Hu, Xiao-Yang Han, Mei Robinson, Nicola Liu, Jian-Ping Eur J Integr Med Article Published by Elsevier GmbH 2021-12 2021-12-17 /pmc/articles/PMC8696019/ http://dx.doi.org/10.1016/j.eujim.2021.101979 Text en Copyright © 2021 Published by Elsevier GmbH. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Liang, Shi-Bing Zhang, Ying-Ying Fang, Min Liang, Chang-Hao Lan, Hui-Di Shen, Chen Yan, Li-Jiao Hu, Xiao-Yang Han, Mei Robinson, Nicola Liu, Jian-Ping Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials |
title | Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials |
title_full | Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials |
title_fullStr | Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials |
title_full_unstemmed | Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials |
title_short | Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials |
title_sort | therapeutic effects and safety of oral chinese patent medicine for covid-19: a rapid systematic review and meta-analysis of randomized controlled trials |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696019/ http://dx.doi.org/10.1016/j.eujim.2021.101979 |
work_keys_str_mv | AT liangshibing therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT zhangyingying therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT fangmin therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT liangchanghao therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT lanhuidi therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT shenchen therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT yanlijiao therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT huxiaoyang therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT hanmei therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT robinsonnicola therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT liujianping therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials |